These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20331602)

  • 1. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.
    Ceron CS; Castro MM; Rizzi E; Montenegro MF; Fontana V; Salgado MC; Gerlach RF; Tanus-Santos JE
    Br J Pharmacol; 2010 May; 160(1):77-87. PubMed ID: 20331602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
    Marçal DM; Rizzi E; Martins-Oliveira A; Ceron CS; Guimaraes DA; Gerlach RF; Tanus-Santos JE
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):35-44. PubMed ID: 21058008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
    Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
    Guimarães DA; Rizzi E; Ceron CS; Martins-Oliveira A; Gerlach RF; Shiva S; Tanus-Santos JE
    Redox Biol; 2015 Dec; 6():386-395. PubMed ID: 26343345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
    Ceron CS; Rizzi E; Guimaraes DA; Martins-Oliveira A; Cau SB; Ramos J; Gerlach RF; Tanus-Santos JE
    Matrix Biol; 2012 May; 31(4):261-70. PubMed ID: 22342460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
    Pereira SC; Parente JM; Belo VA; Mendes AS; Gonzaga NA; do Vale GT; Ceron CS; Tanus-Santos JE; Tirapelli CR; Castro MM
    Atherosclerosis; 2018 Mar; 270():146-153. PubMed ID: 29425960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
    Mattos BR; Bonacio GF; Vitorino TR; Garcia VT; Amaral JH; Dellalibera-Joviliano R; Franca SC; Tanus-Santos JE; Rizzi E
    Biochem Pharmacol; 2020 Oct; 180():114121. PubMed ID: 32592722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension.
    Cau SB; Guimaraes DA; Rizzi E; Ceron CS; Souza LL; Tirapelli CR; Gerlach RF; Tanus-Santos JE
    Br J Pharmacol; 2011 Sep; 164(2):372-81. PubMed ID: 21434884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects.
    Rizzi E; Amaral JH; Guimarães DA; Conde-Tella SO; Pinheiro LC; Gerlach RF; Castro MM; Tanus-Santos JE
    Free Radic Biol Med; 2019 Jan; 130():234-243. PubMed ID: 30399409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS; Rizzi E; Guimarães DA; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():47-56. PubMed ID: 23806385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Guimaraes DA; Ceron CS; Prado CM; Pinheiro LC; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2014 Aug; 73():308-17. PubMed ID: 24933619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension.
    Cau SB; Guimaraes DA; Rizzi E; Ceron CS; Gerlach RF; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):234-41. PubMed ID: 25816715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress.
    da Costa CA; de Oliveira PR; de Bem GF; de Cavalho LC; Ognibene DT; da Silva AF; Dos Santos Valença S; Pires KM; da Cunha Sousa PJ; de Moura RS; Resende AC
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Dec; 385(12):1199-209. PubMed ID: 23052352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE
    Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
    Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension.
    Montenegro MF; Neto-Neves EM; Dias-Junior CA; Ceron CS; Castro MM; Gomes VA; Kanashiro A; Tanus-Santos JE
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):293-301. PubMed ID: 20694791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
    Martinez ML; Rizzi E; Castro MM; Fernandes K; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Dec; 599(1-3):110-6. PubMed ID: 18930722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hydrogen sulfide donor 4-carboxyphenyl-isothiocyanate decreases blood pressure and promotes cardioprotective effect through reduction of oxidative stress and nuclear factor kappa B/matrix metalloproteinase (MMP)-2 axis in hypertension.
    Pernomian L; Blascke de Mello MM; Parente JM; Sanches-Lopes JM; Tanus-Santos JE; Parreiras E Silva LT; Antunes-Rodrigues J; da Conceição Dos Santos R; Elias LLK; Fabro AT; Silva CAA; Fazan R; de Castro MM
    Life Sci; 2024 Aug; 351():122819. PubMed ID: 38857651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
    Castro MM; Rizzi E; Ceron CS; Guimaraes DA; Rodrigues GJ; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Nitric Oxide; 2012 Mar; 26(3):162-8. PubMed ID: 22327038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.